In the head-to-head SURMOUNT-5 trial (NEJM, 2025), tirzepatide produced 20.2% body weight loss vs 13.7% for semaglutide at 72 weeks, with similar side-effect profiles
Animal studies involving intranasal administration of epithalon have shown that it can rapidly access the brain and induce neuronal activity, potentially speeding up onset of action compared to epithalon administered via injection [3, 17]
This enzyme is crucial for fat synthesis
Research focus centers on sustained receptor engagement and how the compound facilitates communication across expansive metabolic frameworks
This balance is vital for comfort and hygiene
The in vitro experiments were performed using TM3 mouse Leydig cells that were cultured in DMEM/F-12 medium supplemented with 5% horse serum and 2.5% fetal bovine serum, and maintained at 37C under a 5% CO2 atmosphere